Applied Genetic Tech
Earnings Details
2nd Quarter December 2019
Tweet Share Watch

Applied Genetic Tech (AGTC) Recent Earnings

Applied Genetic Tech (AGTC) reported a 2nd Quarter December 2019 loss of $0.47 per share on revenue of $2.5 million. The consensus estimate was a loss of $0.59 per share. Revenue fell 58.7% compared to the same quarter a year ago.

Applied Genetic Technologies Corp is a clinical-stage biotechnology company. It is primarily developing gene therapy products designed to transform the lives of patients with severe inherited orphan diseases in ophthalmology.

Reported Earnings
Earnings Whisper
Consensus Estimate
Reported Revenue
$2.5 Mil
Revenue Estimate
Earnings Growth
Revenue Growth
Power Rating
Earnings Release